News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
FDA Rejects Johnson & Johnson (JNJ)'s RA Drug Sirukumab, More Safety Data Needed     9/25/2017
19 Deaths, Serious Liver Injury Linked to Intercept Pharma (ICPT)'s Ocaliva     9/22/2017
3 Biotechs With Make-or-Break Trial Results, FDA Meetings Coming Soon     9/22/2017
Bay Area Versartis (VSAR)'s Stock Collapses as Growth Hormone Drug Flunks Phase III Test     9/22/2017
Alnylam (ALNY) Stock Catapults as Genetic Disease Drug Meets All Phase III Goals     9/21/2017
Eli Lilly (LLY) Heads to Finish Line with Breast Cancer Treatment Abemaciclib     9/21/2017
New Kid on the Block Provention Bio Snags 2 Clinic-Ready Immune Compounds From Johnson & Johnson (JNJ)     9/21/2017
Roche (RHHBY) Slammed With Partial Holds for Two Combo Cancer Trials     9/20/2017
Nabriva (NBRV)'s Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials     9/19/2017
Bill & Melinda Gates Foundation Sinks $40 Million Into Immunocore for Infectious Disease R&D     9/19/2017
Amgen (AMGN), Allergan (AGN) Make History With First Cancer Biosimilar OK—Will Take on Genentech (RHHBY)'s $6 Billion Best-Seller     9/18/2017
Show Me The Money: Bay Area’s Top 5 Venture Capital-Backed Biotechs     9/18/2017
This Regeneron (REGN) Drug Just Took Another Step Toward Blockbuster Status     9/15/2017
Bavarian Nordic (BAVA.CO) Plummets 49% After Cancer Vaccine Flunks Late-Stage Test     9/15/2017
Secretive Moderna Shakes Up R&D Model, Shows Off Early-Stage Trial Data     9/15/2017

News from Around the Web
NIST's Quick Test May Speed Antibiotic Treatment And Combat Drug Resistance     9/22/2017
How Will Artificial Intelligence Impact Alzheimer’s Research?     9/21/2017
UK Warns About Alarm Failure for Roche (RHHBY)’s Accu-Check Insight Insulin Pumps     9/21/2017
People With Schizophrenia Have Threefold Risk Of Dying, Canadian Medical Association Journal Reveals     9/20/2017
No More 'Bad Fat'? A Potential Weight-Loss Treatment Could Make Fat Burn Itself, Washington University in St. Louis Study Reveals     9/20/2017
New Assay Leads To Step Toward Gene Therapy For Deaf Patients, Oregon State University Study     9/20/2017
Fluorescence Microscopy On A Chip: No Lenses Required, American Institute of Physics Reveals     9/20/2017
New Bionic-Eye Brain Implants Could Help More Blind People Than A Device Already On The Market     9/20/2017
Will You Lose Weight? Take A Look At Your Poop, University of Copenhagen Study Reveals     9/19/2017
Down But Not Out: Juno (JUNO) Preps For Second Round Of CAR-T Cancer War     9/18/2017
Love Handles Get Dissolved By New Skin Patch, University of North Carolina Study Reveals     9/18/2017
IBM (IBM) Pitched Its Watson Supercomputer As A Revolution In Cancer Care. It’s Nowhere Close     9/18/2017
New Flexible, Organic Battery Could Revolutionize Medical Implants, Queen’s University Study Reveals     9/18/2017
How BIOHM's At Home Candida Test Is Giving Consumers Peace of Mind     9/18/2017
Vitamin D Levels May Help Predict Risk Of MS, Neurology Reveals     9/15/2017

Press Releases
FDA Turns Down Intellipharmaceutics (IPCI)'s Opiod Painkiller Rexista     9/25/2017
AstraZeneca PLC (AZN)'s COPD Drug Bevespi Aerosphere Scores a Phase III Win     9/25/2017
Shionogi Announces Results For Lusutrombopag (S-888711) Phase III Study (L-PLUS2) For The Treatment Of Thrombocytopenia In Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures     9/25/2017
Sinovac Biotech Ltd. (SVA) Reports Preliminary Top-Line Results From Phase III Clinical Trial For Varicella Vaccine Candidate Against Chickenpox     9/25/2017
Arbutus Biopharma (ABUS) Announces Topline Results For ARB-1467 Phase II Cohort 4     9/25/2017
Intercept Pharma (ICPT) Statement Regarding Ocaliva (Obeticholic Acid) Safety And Dosing In Primary Biliary Cholangitis (PBC) Patients     9/25/2017
China Food And Drug Administration Approves Gilead (GILD)’s Sovaldi (Sofosbuvir) For Treatment Of Chronic Hepatitis C Virus Infection     9/25/2017
Allergan (AGN) Receives Refusal To File Letter From FDA For Vraylar (Cariprazine) Supplemental New Drug Application (Snda) For The Treatment Of Negative Symptoms In Schizophrenia     9/25/2017
Janssen R&D Submits New Drug Application To FDA For The First Darunavir-Based Single Tablet Regimen For The Treatment Of HIV-1     9/25/2017
Soleno Therapeutics Announces Receipt Of Scientific Advice From The EMA For DCCR In Prader-Willi Syndrome     9/25/2017
CureMark Completes Enrollment For Its Phase III Clinical Trial For Children With Autism - The Blüm Study     9/25/2017
Athenex Announces First Patient Recruitment In Phase III Clinical Trials For KX-01 Ointment For Actinic Keratosis     9/25/2017
Melinta Presenting Detailed Analyses From Baxdela Phase III ABSSSI Trials And In Vitro Performance Against Isolates Of Resistant CABP And Other Infections     9/25/2017
American Society For Radiation Oncology Release: Phase III Trial Confirms Pelvic Radiation As Standard Of Care For High-Risk, Early-Stage Endometrial Cancer     9/25/2017
American Society For Radiation Oncology Release: Radiation-Immunotherapy Combination Can Slow Tumor Growth For Some Patients With Metastatic Late-Stage Cancer     9/25/2017